Xlear nasal spray is generally safe for most adults when used as directed. It contains xylitol and saline rather than the decongestant chemicals found in sprays like Afrin, which means it does not carry the risk of rebound congestion that makes those products problematic with prolonged use. That said, there are some nuances worth understanding, especially regarding one of its ingredients, its use in children, and what the science actually shows about its effectiveness.
What’s in Xlear and How It Works
Xlear’s active formula is straightforward: xylitol (a sugar alcohol), saline, and grapefruit seed extract. Xylitol works as an osmolyte, meaning it changes the salt concentration of the thin layer of liquid lining your nasal passages. This shift may help your nose’s natural defenses work more effectively against bacteria. The xylitol also draws moisture into the nasal lining, which helps keep things hydrated and makes it harder for bacteria and viruses to stick to the tissue. Grapefruit seed extract is included for its antibacterial properties.
The product is marketed as “drug-free,” meaning it doesn’t contain pharmaceutical decongestants like oxymetazoline or phenylephrine. The FDA approved xylitol as a food additive back in 1963 and also regulates it as a cosmetic ingredient, but it is not classified as a drug.
No Risk of Rebound Congestion
One of the biggest safety concerns people have with nasal sprays is rebound congestion, the frustrating cycle where your nose gets more stuffed up the longer you use a decongestant spray. This condition, called rhinitis medicamentosa, is caused specifically by chemicals like oxymetazoline and phenylephrine found in products such as Afrin and Neo-Synephrine. Xlear doesn’t contain either of these ingredients.
Saline-based sprays, which is essentially what Xlear is (with added xylitol), do not cause rebound congestion according to the Cleveland Clinic. This means you can use Xlear regularly without worrying about creating a dependency or making your congestion worse over time.
The Grapefruit Seed Extract Question
Grapefruit seed extract is the ingredient that raises the most eyebrows. Some researchers have questioned whether commercially available grapefruit seed extract owes its antimicrobial properties to the grapefruit itself or to synthetic preservatives sometimes found in the extract during manufacturing. The concentrations used in nasal sprays like Xlear are small, and it has been included in clinical trial formulations, including one registered on ClinicalTrials.gov studying xylitol-based nasal spray for respiratory illness. No serious adverse reactions from the grapefruit seed extract component have been flagged in these trials, but it’s worth knowing the ingredient has been debated in the broader supplement world.
What the Clinical Evidence Shows
A handful of studies have looked at xylitol nasal spray for conditions ranging from sinus infections to allergic rhinitis to COVID-19. A clinical trial registered in 2022 examined the xylitol and grapefruit seed extract combination for treating COVID-19, based on the theory that these ingredients could reduce viral adhesion in the nasal passages. Research from the early 2000s showed that xylitol could enhance the nasal lining’s natural ability to kill bacteria by altering salt concentrations in the airway surface liquid.
Adding xylitol to saline nasal irrigation has been shown to help clear sinus infections in children. However, a study published in the International Journal of Pediatric Otorhinolaryngology found that xylitol irrigation was “not recommended as a first-line treatment for pediatric chronic sinusitis” because of low tolerance, poor compliance, and side effects. The xylitol solution didn’t outperform standard saline in quality-of-life scores for children with chronic sinus problems. In other words, xylitol may offer some benefits over plain saline in specific situations, but the evidence for a dramatic advantage is limited.
Safety for Children and During Pregnancy
Xlear’s labeling on DailyMed, the FDA’s drug label database, states that the product is not for children under age 6 unless directed by a physician. Children ages 6 through adulthood can use one to two sprays in each nostril, no more than every 10 to 12 hours, with adult supervision for younger users.
If you’re pregnant or breastfeeding, the label advises asking a health professional before use. This is a standard precaution for most nasal products rather than a signal of a known risk specific to xylitol.
Possible Side Effects
Xlear is mild compared to medicated nasal sprays, but it’s not completely without side effects. Some users report a mild burning or stinging sensation, particularly if the nasal lining is already irritated or cracked from dryness. Sneezing after application is also common. These reactions are typical of any saline-based spray and tend to be brief.
Because xylitol draws moisture into the nasal lining, some people find it more soothing than plain saline, while others with very sensitive nasal tissue may notice temporary discomfort from the osmotic effect. If stinging persists beyond the first few uses or gets worse, it’s reasonable to switch to a plain saline spray to see if the xylitol or grapefruit seed extract is contributing.
Regulatory History and Health Claims
Xlear’s safety profile is separate from the controversy around how the company has marketed its products. In 2021, the FTC sued Xlear’s parent company and founder Nathan Jones over marketing claims that the nasal spray could prevent or treat COVID-19. The FTC dropped that lawsuit in March 2025, but the case highlighted an important distinction: Xlear is not FDA-approved to treat, cure, or prevent any disease. The company itself acknowledges this, with Jones stating publicly that making specific health claims about xylitol would constitute drug claims that the product’s classification doesn’t support.
This doesn’t mean the spray is unsafe. It means that any claims about it preventing infections or treating specific illnesses go beyond what regulatory agencies have verified. As a nasal moisturizer and saline alternative, it occupies well-established, low-risk territory. As a treatment for anything specific, the evidence isn’t strong enough to draw firm conclusions.